Ingevity (NYSE: NGVT) recently received a number of ratings updates from brokerages and research firms:
- 8/7/2024 – Ingevity was upgraded by analysts at CJS Securities from a “market perform” rating to an “outperform” rating. They now have a $58.00 price target on the stock.
- 8/5/2024 – Ingevity had its price target lowered by analysts at BMO Capital Markets from $45.00 to $42.00. They now have a “market perform” rating on the stock.
- 8/5/2024 – Ingevity had its price target lowered by analysts at Wells Fargo & Company from $45.00 to $40.00. They now have an “equal weight” rating on the stock.
- 8/1/2024 – Ingevity had its price target lowered by analysts at Oppenheimer Holdings Inc. from $58.00 to $50.00. They now have an “outperform” rating on the stock.
- 7/11/2024 – Ingevity had its price target lowered by analysts at Wells Fargo & Company from $55.00 to $45.00. They now have an “equal weight” rating on the stock.
Ingevity Stock Performance
Shares of NGVT traded down $0.47 during midday trading on Tuesday, reaching $36.30. 139,188 shares of the stock were exchanged, compared to its average volume of 240,626. The stock’s 50 day simple moving average is $42.27 and its 200 day simple moving average is $45.84. The company has a market cap of $1.32 billion, a P/E ratio of -11.67 and a beta of 1.66. Ingevity Co. has a twelve month low of $33.49 and a twelve month high of $56.29. The company has a quick ratio of 0.98, a current ratio of 1.92 and a debt-to-equity ratio of 4.92.
Ingevity (NYSE:NGVT – Get Free Report) last issued its quarterly earnings data on Wednesday, July 31st. The company reported $1.01 earnings per share for the quarter, missing the consensus estimate of $1.05 by ($0.04). Ingevity had a positive return on equity of 19.59% and a negative net margin of 27.85%. The business had revenue of $390.60 million during the quarter, compared to analyst estimates of $407.58 million. During the same quarter last year, the firm earned $1.41 EPS. Ingevity’s revenue for the quarter was down 18.9% compared to the same quarter last year. On average, sell-side analysts expect that Ingevity Co. will post 3.47 earnings per share for the current year.
Institutional Trading of Ingevity
Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.
Featured Articles
- Five stocks we like better than Ingevity
- What Are Dividends? Buy the Best Dividend Stocks
- Columbia Sportswear: A Turnaround Story That’s Gaining Ground
- High Flyers: 3 Natural Gas Stocks for March 2022
- Lowe’s Stock: Hold Now, Buy it When it Dips
- 3 Fintech Stocks With Good 2021 Prospects
- ZIM Shipping Stock Soars as the Industry Shows a Bottoming Trend
Receive News & Ratings for Ingevity Co Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity Co and related companies with MarketBeat.com's FREE daily email newsletter.